Page last updated: 2024-11-03

risperidone and Diseases in Twins

risperidone has been researched along with Diseases in Twins in 2 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Diseases in Twins: Disorders affecting TWINS, one or both, at any age.

Research Excerpts

ExcerptRelevanceReference
"The increasing recognition of Tourette's syndrome is probably responsible for the broadening range of symptom severities seen in clinic patients."2.39Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome. ( Peterson, BS, 1996)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Markovic, J1
Plestic, S1
Kostic, J1
Peterson, BS1

Reviews

1 review available for risperidone and Diseases in Twins

ArticleYear
Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome.
    The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 9

    Topics: Adolescent; Adult; Age of Onset; Antipsychotic Agents; Child; Clozapine; Disease Progression; Diseas

1996

Other Studies

1 other study available for risperidone and Diseases in Twins

ArticleYear
Concordant response to pharmacotherapy in monozygotic twins with schizoaffective disorder.
    European review for medical and pharmacological sciences, 2013, Volume: 17, Issue:23

    Topics: Affect; Alopecia; Antipsychotic Agents; Diseases in Twins; Drug Therapy, Combination; Emotions; Huma

2013